How the US locked up vaccine materials other nations urgently need | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
June 10, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, JUNE 10, 2025
How the US locked up vaccine materials other nations urgently need

Coronavirus chronicle

Reuters
07 May, 2021, 10:20 pm
Last modified: 07 May, 2021, 10:24 pm

Related News

  • India, US push to finalise interim tariff deal as Trump's deadline nears
  • US and Europe trade negotiators discuss tariffs in Paris
  • Clamping down: Once Japan, now China
  • Elon Musk leaving Trump administration, capping turbulent tenure
  • Touhid expresses concern over widespread rumour campaigns during meeting with USCIRF chair

How the US locked up vaccine materials other nations urgently need

Countries ravaged by the virus - including India, where a catastrophic explosion of cases has filled hospitals and morgues - cannot make vaccines without such supplies, even with access to manufacturers' cookbooks

Reuters
07 May, 2021, 10:20 pm
Last modified: 07 May, 2021, 10:24 pm
Stickers that are given to people who have been vaccinated against the coronavirus disease (COVID-19) are pictured in Los Angeles, California, U.S., April 12, 2021. REUTERS/Lucy Nicholson
Stickers that are given to people who have been vaccinated against the coronavirus disease (COVID-19) are pictured in Los Angeles, California, U.S., April 12, 2021. REUTERS/Lucy Nicholson

To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots.

As a result, the US government laid claim not only to vast quantities of finished Covid-19 vaccines but also to vaccine components and equipment all along the supply chain, according to a Reuters review of more than a dozen contracts involving some major suppliers.

That has left some countries desperately in need of those supplies to scramble for substitutes, exacerbating international disparities in vaccine access, according to interviews with suppliers, foreign manufacturers and vaccine market experts.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

On Wednesday, President Joe Biden threw his support behind waiving patents for Covid-19 vaccines, thrilling those who have been pressuring his administration to help speed production of doses worldwide. If adopted by the World Trade Organization, the move would let other countries make their own copies of the much-coveted shots.

But the waiver would not address a less conspicuous but equally pressing problem: the growing worldwide shortage of vaccine ingredients and manufacturing equipment. The United States has a tight grip on a significant amount of those materials, such as filters, tubing and specialized disposable bags essential to making vaccines.

Countries ravaged by the virus - including India, where a catastrophic explosion of cases has filled hospitals and morgues - cannot make vaccines without such supplies, even with access to manufacturers' cookbooks.

The problem stems from the US reliance on a law dating to the Korean War in the 1950s, called the Defense Production Act (DPA), which gives federal agencies the power to prioritize procurement orders related to national defense. For decades, the law was used to supply the military as well as respond to everything from natural disasters to roadblocks in the decennial US census.

The administration of former President Donald Trump invoked the act to put the US government first in line to buy American-made vaccines as well as other products needed to fight the Covid-19 pandemic. In turn, vaccine makers have priority access to any supplies needed to fill US orders.

Gavi - a vaccine alliance comprising international organizations, governments, drug companies and others - lauded the Biden administration's moves to increase global access to vaccines. Among other things, it cited the country's $4 billion commitment to COVAX, a global vaccine buying consortium Gavi co-leads with the World Health Organization.

But in response to questions about the DPA, Gavi said: "The greatest challenge to COVAX's goal of equitable access to vaccines is constrained global supply. Export controls on raw materials is a considerable contributor to this and ultimately only serve to prolong the pandemic."

A senior Biden administration official, speaking on condition of anonymity, said there is no export ban, and all US-based suppliers continue to ship products abroad after giving priority to US manufacturers. The official said the DPA has not caused the global shortages of vaccine materials, and the problems stem instead from overwhelming demand.

"There's just not enough to go around," the official said, noting that the administration is investing in increased raw material production.

On Wednesday, Katherine Tai, the US trade representative, briefly mentioned in her statement about Biden's patent decision that the administration would "work to increase the raw materials needed" to make vaccines. She did not elaborate.

A Plea From India

Vaccine components are produced all over the globe - in countries including the United Kingdom and China. But some leading suppliers, including Thermo Fisher Scientific Inc, and the Danaher Corp units Cytiva and Pall, are based in the United States. Reuters could not determine precisely what share of vaccine materials and equipment are made in America.

The DPA has helped the United States build a huge vaccine production system, ensuring reliable access to finished doses for Americans, and driving up revenue for US pharmaceutical companies.

About 45% of the US population has received at least one dose of a Covid-19 vaccine. Dozens of other countries, from South Africa, to Guatemala, to Thailand, have vaccinated about 1% or less of their populations, according to data collected at the University of Oxford in the United Kingdom.

The DPA has drawn criticism from vaccine makers around the world, including the Serum Institute of India, the largest manufacturer globally.

On Twitter in late April, chief executive Adar Poonawalla requested "on behalf of the vaccine industry outside the United States" that America lift its hold on raw materials "if we are to truly unite in beating this virus."

Starting this month, the company had planned to produce a billion doses annually of a vaccine developed by US-based Novavax Inc. But that output will be more than halved without American raw materials, according to a source familiar with the company's plans, speaking on condition of anonymity.

Serum is also manufacturing COVISHIELD, a licensed version of the AstraZeneca Plc vaccine.

After weeks of public appeals from the Serum, the United States last month offered India filters needed to produce COVISHIELD. But India's need for vaccines and supplies remains vast. Serum is also meant to be a top supplier to other low- and middle-income countries. COVISHIELD and the Novavax shot form the backbone of the COVAX program.

Serum, which declined to discuss the raw materials issue with Reuters, is not the only vaccine maker in need.

The South African vaccine maker Biovac Institute also relies on a US company for bioreactor bags, needed for cell cultures. Biovac has been warned by its US supplier that the usual lead time for bags may more than double to 14 months because of the US DPA, chief executive Morena Makhoana told Reuters.

Manufacturers in some other countries say they are in better shape. Brazil's Butantan Institute has been able to buy supplies from both the United States and Europe, an executive told Reuters.

For instance, an order for supplies to make AstraZeneca's vaccine in the United States would be prioritized, even though the shot is not yet approved for use in the country. That could delay materials being sent to Serum, which is making the same vaccine for use in India and many other countries.

For now, three manufacturers' Covid-19 vaccines - Pfizer Inc, Moderna Inc and Johnson & Johnson - are approved for emergency use in the United States.

Asked about the global consequences of getting priority on US supplies, AstraZeneca did not comment and Moderna and J&J declined to comment. Pfizer did not directly address the US DPA but said "we have gone to enormous efforts … as we seek to serve populations all over the world."

'Unprecedented Demand'

Some suppliers say the industry would do a better job than governments at managing limited resources to maximize access globally.

"If the end goal is, let's produce vaccines, then we're big believers that you need to let the industry connect the relevant parts so that we can deliver the end product," Thermo Fisher executive vice president Michel Lagarde told Reuters.

The Biden administration official said experts from various federal agencies discuss the use of the priority system during daily operations calls. Sometimes officials can change US delivery dates to avoid disrupting other vaccine projects abroad.

But suppliers are planning to get ahead of demand. Leading purveyors Cytiva, Pall and Thermo Fisher are expanding manufacturing space in the United States and abroad. Thermo Fisher has nudged customers to clarify which needs are urgent and which can wait days or weeks, and the company tries to find time to fill orders even if they are not rated as priorities, Lagarde said.

Cytiva said in a statement that it is expanding production, but is itself limited by some raw materials shortages.

"The world is experiencing an unprecedented demand for biopharmaceutical products, technologies, and solutions," Cytiva said.

Top News / World+Biz

How / US / locked / Vaccine / materials / Nations / urgently / need

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Chief Adviser Muhammad Yunus leaves for a four-day visit to the United Kingdom from the Dhaka airport on 9 June 2025. Photo: CA Press Wing
    CA Yunus leaves for UK; discussion expected on renewable energy investment, laundered money
  • Donald Trump. Photo: Reuters
    Trump defends sending National Guard to LA as California governor to sue administration
  • California Governor Gavin Newsom. File Photo: REUTERS/Fred Greaves
    California Governor Newsom to sue Trump over National Guard deployment amid LA protests

MOST VIEWED

  • On left, Abdullah Hil Rakib, former senior vice president (SVP) of BGMEA and additional managing director of Team Group; on right, Captain Md Saifuzzaman (Guddu), a Boeing 787 Dreamliner pilot for Biman Bangladesh Airlines. Photos: Collected
    Ex-BGMEA SVP Abdullah Hil Rakib, Biman 787 pilot Saifuzzaman drown in boating accident in Canada
  • A photo showing the former president on his return to Dhaka today (9 June). 
Source: Collected
    Former president Abdul Hamid returns to Bangladesh from Thailand
  • File Photo: British MP Tulip Siddiq attends a news conference with Richard Ratcliffe, the husband of jailed British-Iranian aid worker Nazanin Zaghari-Ratcliffe, in London, Britain October 11, 2019. Photo: REUTERS/Peter Nicholls/File Photo
    Tulip requests CA Yunus for a meeting over corruption allegations: Guardian
  • Representational image. Photo: Reuters
    Bangladesh reports 3 more Covid-19 cases
  • Muhammad Yunus (L) and Narendra Modi. Photo: Collected
    Modi sends Eid-ul-Adha greetings, Yunus calls for continued bilateral cooperation
  • Photo: Reuters
    Trump says Musk relationship over, warns of 'serious consequences' if he funds Democrats

Related News

  • India, US push to finalise interim tariff deal as Trump's deadline nears
  • US and Europe trade negotiators discuss tariffs in Paris
  • Clamping down: Once Japan, now China
  • Elon Musk leaving Trump administration, capping turbulent tenure
  • Touhid expresses concern over widespread rumour campaigns during meeting with USCIRF chair

Features

File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

20h | Features
Photo collage shows political posters in Bagerhat. Photos: Jannatul Naym Pieal

From Sheikh Dynasty to sibling rivalry: Bagerhat signals a turning tide in local politics

2d | Bangladesh
Illustration: TBS

Unbearable weight of the white coat: The mental health crisis in our medical colleges

5d | Panorama
(From left) Sadia Haque, Sylvana Quader Sinha and Tasfia Tasbin. Sketch: TBS

Meet the women driving Bangladesh’s startup revolution

5d | Panorama

More Videos from TBS

US and China to meet in London for trade talks

US and China to meet in London for trade talks

9h | TBS World
The forbidden point on Cox's Bazar beach is like a death trap

The forbidden point on Cox's Bazar beach is like a death trap

11h | TBS Today
Israeli forces seize Gaza aid boat carrying Greta Thunberg

Israeli forces seize Gaza aid boat carrying Greta Thunberg

13h | TBS World
Which way will the anti-immigration campaign in Los Angeles turn?

Which way will the anti-immigration campaign in Los Angeles turn?

14h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net